Yafang Kang
Overview
Explore the profile of Yafang Kang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang Y, Kang Y, Li Y, Cai L, Wu Q, Liu D, et al.
Eur J Clin Microbiol Infect Dis
. 2024 Jan;
43(3):469-480.
PMID: 38172404
Purpose: Few studies have focused on the impact of human papillomavirus (HPV) positivity in male partners on female HPV infection and cervical lesions. The purpose of this study was to...
2.
Dang R, Yang Y, Kang Y, Tan H
Spectrochim Acta A Mol Biomol Spectrosc
. 2023 Aug;
303:123244.
PMID: 37572446
In museums, there is a huge storage of Xuan paper cultural relics with profound historical and artistic significances. Exploring the photochemical damage behavior of Xuan paper that is generally in...
3.
Li Y, Feng Y, Chen Y, Lin W, Gao H, Chen M, et al.
Virol J
. 2023 May;
20(1):80.
PMID: 37127618
Background: There is a close correlation between HPV infection and systemic immune status. The purpose of this study was to determine which lymphocytes in peripheral blood influence human papillomavirus (HPV)...
4.
Dong B, Zou H, Mao X, Su Y, Gao H, Xie F, et al.
Ther Adv Med Oncol
. 2021 May;
13:17588359211010939.
PMID: 33995595
Background: China's Fujian Cervical Pilot Project (FCPP) transitioned cervical cancer screening from high-risk human papillomavirus (HR-HPV) nongenotyping to genotyping. We investigated the clinical impact of this introduction, comparing performance indicators...
5.
Dong B, Chen L, Lin W, Su Y, Mao X, Pan D, et al.
Cancer Cell Int
. 2020 Sep;
20:421.
PMID: 32868973
Background: New screening techniques may affect the optimal approaches for the prevention of cervical cancer. We evaluated the cost-effectiveness and accuracy of alternative screening strategies to provide evidence for cervical...
6.
Chen L, Dong B, Zhang Q, Mao X, Lin W, Ruan G, et al.
Med Oncol
. 2020 Apr;
37(5):37.
PMID: 32232578
The relationship between high-risk-human-papillomavirus (HR-HPV) viral loads and residual/recurrence lesion is uncertain. This study aimed to evaluate the clinical value of HR-HPV viral loads to predict the residual/recurrence lesions among...
7.
Kang Y, Sun P, Mao X, Dong B, Ruan G, Chen L
J Gynecol Oncol
. 2019 Mar;
30(3):e29.
PMID: 30887754
Objective: To evaluate the polymerase chain reaction (PCR)-reverse-dot-blot (RDB) human papillomavirus (HPV) genotyping test as a feasible assay for the cervical cancer primary screening. Methods: In a hospital-based cohort, a...
8.
Dong B, Sun P, Ruan G, Huang W, Mao X, Kang Y, et al.
Cancer Manag Res
. 2018 Nov;
10:4839-4851.
PMID: 30425576
Purpose: Currently, the associations between type-specific high-risk human papillomavirus (HR-HPV) viral loads and cervical lesions are still inconsistent. We aimed to assess the type-specific HR-HPV viral load as a risk...
9.
Ruan G, Song Y, Dong B, Mao X, Lin F, Kang Y, et al.
Cancer Manag Res
. 2018 Sep;
10:3227-3235.
PMID: 30233239
Objectives: The Cervista high-risk human papillomavirus (HR-HPV) test was evaluated as a primary screening method for cervical cancer in women aged ≥21 years and was compared with different screening and...
10.
Sun P, Song Y, Ruan G, Mao X, Kang Y, Dong B, et al.
J Gynecol Oncol
. 2017 Jun;
28(5):e50.
PMID: 28657218
Objective: To determine the clinical significance of the polymerase chain reaction (PCR)-reverse dot blot (RDB) human papillomavirus (HPV) genotyping assay in cervical cancer screening. Methods: A total of 10,442 women...